RXi Pharmaceuticals makes board appointment
This article was originally published in Scrip
Executive Summary
RXi Pharmaceuticals, a US biopharmaceutical company focused on the development and commercialisation of therapeutics based on RNAi, has appointed Dr Richard Chin, chief executive officer of the Institute for OneWorld Health, to its board of directors.